We found a match
Your institution may have access to this item. Find your institution then sign in to continue.
- Title
Comparison of the systemic bioavailability of mometasone furoate after oral inhalation from a mometasone furoate/formoterol fumarate metered-dose inhaler versus a mometasone furoate dry-powder inhaler in patients with chronic obstructive pulmonary disease.
- Authors
Kosoglou, Teddy; Hubbell, James; Xuan, Fengjuan; Cutler, David L; Meehan, Alan G; Kantesaria, Bhavna; Wittmer, Bret A
- Abstract
Coadministration of mometasone furoate (MF) and formoterol fumarate (F) produces additive effects for improving symptoms and lung function and reduces exacerbations in patients with asthma and chronic obstructive pulmonary disease (COPD). The present study assessed the relative systemic exposure to MF and characterized the pharmacokinetics of MF and formoterol in patients with COPD.
- Publication
International journal of chronic obstructive pulmonary disease, 2013, Vol 8, p107
- ISSN
1178-2005
- Publication type
Journal Article
- DOI
10.2147/COPD.S36592